Rachid Oubelaid

Title: Rachid Oubelaid: Innovator in Alpha-Herpesvirus Production

Introduction

Rachid Oubelaid is a notable inventor based in Vitry-sur-Seine, France. He has made significant contributions to the field of virology, particularly in the production of alpha-herpesviruses. With a total of 2 patents to his name, Oubelaid's work has the potential to enhance the efficiency of virus production in cell cultures.

Latest Patents

Oubelaid's latest patents focus on compositions and methods for the production of alpha-herpesviruses. The inventions relate to virus growth media that improve the yield of alpha-herpesviruses, such as HSV-2, grown in cell cultures. The growth media include two key additives: a disaccharide and a lipid mixture. These additives can be incorporated into serum-free or serum-enriched growth media to enhance the efficiency of virus production. Furthermore, the patents provide methods for producing alpha-herpesviruses in these optimized growth media.

Career Highlights

Rachid Oubelaid is currently associated with Sanofi Pasteur Biologics, LLC, where he continues to innovate in the field of virology. His work is instrumental in advancing the understanding and production of important viral components.

Collaborations

Oubelaid collaborates with esteemed colleagues, including Simon Delagrave and John Hamberger. Their combined expertise contributes to the success of their research and development efforts.

Conclusion

Rachid Oubelaid's contributions to the field of virology, particularly in the production of alpha-herpesviruses, highlight his innovative spirit and dedication to scientific advancement. His patents and ongoing work at Sanofi Pasteur Biologics, LLC, position him as a key figure in this important area of research.